Company intelligence / Profile preview

Invensify

Santa Clara, California, USA

Ownership: Private
Development stage: Other

Overview

Invensify has commercially launched 'Insuridge', an FDA 21 CFR-compliant, power-efficient, real-time monitored shipping system for maintaining cold chain integrity of pharmaceuticals, biologics, and sensitive medical materials in transit. Used by partners in commercial pharmacy and healthcare delivery. As a device company, it does not have clinical results in the traditional sense; its product is commercialized and used in healthcare logistics.

Industry: Therapeutic Medical Devices

Partnerships

Go2 DeliverySenpex

Beyond the preview

Go deeper on Invensify.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invensify.

Explore the full profile